Embodiments of the present disclose provide a method of sorbing one or more compounds from a fluid, wherein the method may include contacting a M-soc-MOF composition with a fluid containing at least H.sub.2S and one or more of CO.sub.2 and CH.sub.4; and sorbing at least H.sub.2S from the fluid. Embodiments of the present disclosure provide a membrane that may include a metal-organic framework (MOF) composition, wherein the MOF composition includes a M-soc-MOF composition, where M is a metal and soc is a square-octahedral topology, and wherein the M-soc-MOF composition is a continuous thin film on a support.

A light-emitting device includes: a first electrode; a second electrode facing the first electrode; and an interlayer between the first electrode and the second electrode and including an emission layer, wherein the interlayer includes a heterocyclic compound of Formula 1:

A.sub.1B.sub.1].sub.n1  Formula 1

wherein, in Formula 1, the variables are defined herein.

Metal Organic Framework (MOF) materials and methods of making MOF materials. The methods include grinding of mixtures of metal hydroxide(s) and ligand(s). The MOF materials may have at least two different ligands. The MOF materials may have open metal sites. The MOF materials can be used in gas storage applications.

The present invention relates to a process for preparing a metal-chelate retarder by a sol-gel method. The method comprises the following steps: weighing calcium nitrate tetrahydrate, aluminum nitrate nonahydrate and ferric nitrate nonahydrate according to a certain mass ratio and adding them into deionized water; placing the mixed solution on a magnetic stirrer and stirring the mixed solution evenly; adding citric acid monohydrate or gluconic acid, ethylene glycol or glycerol, and placing the mixed solution into a water bath to react to obtain the metal-chelate retarder. The process of the present invention has a reliable principle, overcomes the defects of long production period, complex preparation and the like of the existing retarders, has the advantages of simple process operation, cheap and easily available raw materials, and short production period. The prepared retarder has wide temperature adaptation range and adjustable thickening time, is suitable for large-scale industrial production, and has a wide market application prospect.

The present invention relates to a metal-organic framework (MOF) having a three-dimensional porous structure and being represented by the chemical formula of [Al.sub.8(OH).sub.a(BTC).sub.b(IPA).sub.c(L).sub.d], a preparation method therefor, and a use thereof as an adsorbent and a catalyst.

The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FAP ligands for targeting applications, in particular diagnostic methods and/or methods for therapy or surgery in relation to a disease or disorder, such as cancer, inflammation or another disease characterized by overexpression of FAP.

An apparatus for purifying an organic compound and a method of purifying an organic compound, the apparatus including an inner tube that receives a purification target material therein; a heater that heats the purification target material received in the inner tube; an evacuator that evacuates the inner tube into a vacuum; and a driving device that drives the inner tube.

The present invention provides a novel metal alkoxide having excellent hydrolysis resistance, and a crosslinking agent composition for aqueous resin and an aqueous resin composition each using the same. A metal alkoxide represented by the following formula (1-1), (1-2), or (1-3) and having a mass average molecular weight of 800 to 8,500 is used:
Ti(OA).sub.4  (1-1)
Zr(OA).sub.4  (1-2)
Al(OA).sub.3  (1-3) wherein A's are each independently a residue resulting from removal of a hydroxy group from a polyalkylene glycol monohydrocarbyl ether represented by the following general formula (1a):
R.sup.11(OCHR.sup.12CH.sub.2).sub.nOH  (1a) wherein R.sup.11 is an alkyl group having 1 to 4 carbon atoms or a phenyl group; R.sup.12 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; and n is an integer of 4 to 45.

Described herein is a process for preparing inorganic metal-containing films including bringing a solid substrate in contact with a compound of general formula (I) or (II) in the gaseous state ##STR00001## where A is NR.sub.2 or OR with R being an alkyl group, an alkenyl group, an aryl group, or a silyl group, E is NR or O, n is 1, 2 or 3, and R′ is hydrogen, an alkyl group, an alkenyl group, an aryl group, or a silyl group, wherein if n is 2 and E is NR or A is OR, at least one R in NR or OR bears no hydrogen atom in the 1-position.

The present application discloses compositions and methods of synthesis and use of .sup.18F- or .sup.19F-labeled molecules of use in PET, SPECT and/or MR imaging. Preferably, the .sup.18F or .sup.19F is conjugated to a targeting molecule by formation of a complex with a group IIIA metal and binding of the complex to a bifunctional chelating agent, which may then be directly or indirectly attached to the targeting molecule. In other embodiments, the .sup.18F or .sup.19F labeled moiety may comprise a targetable construct used in combination with a bispecific antibody to target a disease-associated antigen. The disclosed methods and compositions allow the simple and reproducible labeling of molecules at very high efficiency and specific activity in 30 minutes or less. In preferred embodiments, the bifunctional chelating agent bound to .sup.18F- or .sup.19F-metal complex may be conjugated to the molecule to be labeled at a reduced temperature, e.g. room temperature.